{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:33Z","timestamp":1793146893710,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470200"],"award-info":[{"award-number":["32470200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170195"],"award-info":[{"award-number":["32170195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303500"],"award-info":[{"award-number":["2022YFC2303500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["23JC1404200"],"award-info":[{"award-number":["23JC1404200"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["22490750200"],"award-info":[{"award-number":["22490750200"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.isci.2025.114091","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:00:41Z","timestamp":1763640041000},"page":"114091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in fungal vaccine development: Progress in the face of emerging challenges"],"prefix":"10.1016","volume":"28","author":[{"given":"Munika","family":"Moses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114091_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: A wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib2","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jof10010080","article-title":"Fungal Infections and Colonization after Bilateral Lung Transplant: A Six-Year Single-Center Experience","volume":"10","author":"Boscolo","year":"2024","journal-title":"J. Fungi"},{"key":"10.1016\/j.isci.2025.114091_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.rcl.2022.01.006","article-title":"Invasive Fungal Pneumonia in Immunocompromised Patients","volume":"60","author":"Godoy","year":"2022","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.isci.2025.114091_bib5","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3201\/eid2811.220361","article-title":"Fungal Endophthalmitis Outbreak after Cataract Surgery, South Korea, 2020","volume":"28","author":"Yoon","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1469-0691.2010.03288.x","article-title":"Epidemiology of invasive fungal infections in neonates and children","volume":"16","author":"Steinbach","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2025.114091_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-2600(23)00408-3","article-title":"Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis","volume":"12","author":"Gioia","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2025.114091_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152257","article-title":"Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis","volume":"63","author":"Xiong","year":"2023","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.isci.2025.114091_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/myc.13579","article-title":"Secondary invasive fungal infection in hospitalised patients with COVID-19 in the United States","volume":"66","author":"Thompson","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.isci.2025.114091_bib10","article-title":"Corticosteroids increase the risk of invasive fungal infections more than tumor necrosis factor-alpha inhibitors in patients with inflammatory bowel disease","volume":"5","author":"Gregory","year":"2023","journal-title":"360"},{"key":"10.1016\/j.isci.2025.114091_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008742","article-title":"Post-tuberculosis chronic pulmonary aspergillosis: An emerging public health concern","volume":"16","author":"Bongomin","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.114091_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","article-title":"The rapid emergence of antifungal-resistant human-pathogenic fungi","volume":"21","author":"Lockhart","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib13","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1038\/s41564-024-01854-z","article-title":"Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida auris","volume":"9","author":"Carolus","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib14","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32386","article-title":"Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates","volume":"10","author":"Das","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2025.114091_bib16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.cmi.2023.03.016","article-title":"Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a One Health approach","volume":"29","author":"Garcia-Bustos","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2025.114091_bib17","doi-asserted-by":"crossref","first-page":"e00360-21","DOI":"10.1128\/mBio.00360-21","article-title":"Environmental Candida auris and the Global Warming Emergence Hypothesis","volume":"12","author":"Casadevall","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/microorganisms12061128","article-title":"Candida spp. in Cetaceans: Neglected Emerging Challenges in Marine Ecosystems","volume":"12","author":"Garcia-Bustos","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.isci.2025.114091_bib19","doi-asserted-by":"crossref","first-page":"e939088","DOI":"10.12659\/MSM.939088","article-title":"Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic","volume":"28","author":"Parums","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.isci.2025.114091_bib20","series-title":"WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action","author":"Organization","year":"2022"},{"key":"10.1016\/j.isci.2025.114091_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","article-title":"The WHO fungal priority pathogens list as a game-changer","volume":"21","author":"Fisher","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jof7030163","article-title":"Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor","volume":"7","author":"Jallow","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.isci.2025.114091_bib23","doi-asserted-by":"crossref","first-page":"e0014223","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","volume":"37","author":"Puumala","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2025.114091_bib24","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis\u2014a phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib25","unstructured":"NCT (2010). Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection. https:\/\/clinicaltrials.gov\/study\/NCT01067131."},{"key":"10.1016\/j.isci.2025.114091_bib26","unstructured":"NCT (2025). Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study. https:\/\/www.centerwatch.com\/clinical-trials\/listings\/NCT06190509\/assessing-the-safety-immune-response-and-early-efficacy-of-a-candida-vaccine-in-women-with-recurrent-vulvovaginal-candidiasis-a-randomized-controlled-study."},{"key":"10.1016\/j.isci.2025.114091_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-021-00294-8","article-title":"Vaccines for human fungal diseases: close but still a long way to go","volume":"6","author":"Oliveira","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib28","first-page":"1136","article-title":"Vaccine development for pathogenic fungi: current status and future directions","volume":"22","author":"Chechi","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib29","doi-asserted-by":"crossref","first-page":"e1639","DOI":"10.1002\/wsbm.1639","article-title":"The yeast\u2013human coevolution: Fungal transition from passengers, colonizers, and invaders","volume":"16","author":"Nenciarini","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100340","article-title":"Vaccination process of immunocompromised patients in the Netherlands: Current challenges and potential solutions","volume":"14","author":"de Laat","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.isci.2025.114091_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2022.105256","article-title":"Genome plasticity in Candida albicans: A cutting-edge strategy for evolution, adaptation, and survival","volume":"99","author":"Mba","year":"2022","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.isci.2025.114091_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","volume":"109","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2025.114091_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2023.1241539","article-title":"Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance","volume":"4","author":"Kumar","year":"2023","journal-title":"Front. Fungal Biol."},{"key":"10.1016\/j.isci.2025.114091_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tim.2017.10.002","article-title":"A call to arms: quest for a cryptococcal vaccine","volume":"26","author":"Caballero Van Dyke","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/mmy\/myw081","article-title":"Aspergillus vaccines: Hardly worth studying or worthy of hard study?","volume":"55","author":"Levitz","year":"2017","journal-title":"Med. Mycol."},{"key":"10.1016\/j.isci.2025.114091_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2024.1446477","article-title":"Recent advances in the clinical development of antifungal vaccines: a narrative review","volume":"5","author":"Alapan","year":"2024","journal-title":"Front. Trop. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib38","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/vaccines11111658","article-title":"Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers","volume":"11","author":"Kaur","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2025.114091_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1146\/annurev-micro-041020-111511","article-title":"Harnessing the Immune Response to Fungal Pathogens for Vaccine Development","volume":"76","author":"Rivera","year":"2022","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib40","unstructured":"NCT (2018). Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis. https:\/\/clinicaltrials.gov\/study\/NCT01926028."},{"key":"10.1016\/j.isci.2025.114091_bib41","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib42","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib43","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"De Bernardis","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114091_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis","volume":"1","author":"Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.isci.2025.114091_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-025-01171-4","article-title":"Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model","volume":"10","author":"Wychrij","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13238","article-title":"Protective effect of fungal extracellular vesicles against murine candidiasis","volume":"22","author":"Vargas","year":"2020","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib48","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2021.06.001","article-title":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans","volume":"39","author":"Adams","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00189-24","article-title":"Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis","volume":"9","author":"Huang","year":"2024","journal-title":"mSphere"},{"key":"10.1016\/j.isci.2025.114091_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.038","article-title":"A novel Candida albicans Als3, Hwp1 and Met6 derived complex peptide protects mice against hematogenously induced candidiasis","volume":"42","author":"Diez","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2406065","article-title":"Dual-antigen fusion protein vaccination induces protective immunity against Candida albicans infection in mice","volume":"20","author":"Jia","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.114091_bib52","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2011.05.030","article-title":"Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/2049-632X.12068","article-title":"An oral vaccine against candidiasis generated by a yeast molecular display system","volume":"69","author":"Shibasaki","year":"2013","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib54","doi-asserted-by":"crossref","first-page":"e02145-19","DOI":"10.1128\/mBio.02145-19","article-title":"A Heat-Killed Cryptococcus Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine Model","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib55","article-title":"Development of a heat-killed fbp1 mutant strain as a therapeutic agent to treat invasive Cryptococcus infection","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.114091_bib56","doi-asserted-by":"crossref","first-page":"e0278521","DOI":"10.1128\/mbio.02785-21","article-title":"Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology","volume":"13","author":"Lin","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00198-23","article-title":"Vaccination with a ZNF2 Oe strain of Cryptococcus provides long-lasting protection against cryptococcosis and is effective in immunocompromised hosts","volume":"91","author":"Pham","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114091_bib58","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.vaccine.2019.10.051","article-title":"Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens","volume":"38","author":"Hester","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib59","doi-asserted-by":"crossref","first-page":"e0336721","DOI":"10.1128\/mbio.03367-21","article-title":"Protection of mice against experimental cryptococcosis by synthesized peptides delivered in glucan particles","volume":"13","author":"Specht","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-025-01079-z","article-title":"Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model","volume":"10","author":"Li","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02328-22","article-title":"Vaccination with live or heat-killed Aspergillus fumigatus \u0394 sglA conidia fully protects immunocompromised mice from invasive aspergillosis","volume":"13","author":"Fernandes","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib62","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2022.05.057","article-title":"Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis","volume":"40","author":"Slarve","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670578","article-title":"Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis","volume":"12","author":"Rayens","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib64","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2021.10.029","article-title":"\u0394cps1 vaccine protects dogs against experimentally induced coccidioidomycosis","volume":"39","author":"Shubitz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib65","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/jof8080838","article-title":"Vaccines to prevent coccidioidomycosis: a gene-deletion mutant of Coccidioides posadasii as a viable candidate for human trials","volume":"8","author":"Galgiani","year":"2022","journal-title":"J. Fungi"},{"key":"10.1016\/j.isci.2025.114091_bib66","doi-asserted-by":"crossref","first-page":"e00070-18","DOI":"10.1128\/IAI.00070-18","article-title":"Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection","volume":"86","author":"Hung","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114091_bib67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/vaccines12010067","article-title":"A recombinant multivalent vaccine (rCpa1) induces protection for C57BL\/6 and HLA transgenic mice against pulmonary infection with both species of coccidioides","volume":"12","author":"Campuzano","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib68","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.vaccine.2021.04.031","article-title":"Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees","volume":"39","author":"Millar","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.114091_bib70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/mmy\/myx139","article-title":"Candida vaginitis: virulence, host response and vaccine prospects","volume":"56","author":"De Bernardis","year":"2018","journal-title":"Med. Mycol."},{"key":"10.1016\/j.isci.2025.114091_bib71","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2015.02.009","article-title":"Calnexin induces expansion of antigen-specific CD4+ T cells that confer immunity to fungal ascomycetes via conserved epitopes","volume":"17","author":"W\u00fcthrich","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2025.114091_bib72","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2025.114091_bib73","first-page":"121","article-title":"Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development","volume":"432","author":"Honorato","year":"2021","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib74","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/biom13101487","article-title":"Immunomodulatory Potential of Fungal Extracellular Vesicles: Insights for Therapeutic Applications","volume":"13","author":"Nenciarini","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2025.114091_bib75","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/microorganisms8111815","article-title":"Nutritional conditions modulate C. neoformans extracellular vesicles\u2019 capacity to elicit host immune response","volume":"8","author":"Marina","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.isci.2025.114091_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12129","article-title":"Cryptococcus extracellular vesicles properties and their use as vaccine platforms","volume":"10","author":"Rizzo","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.isci.2025.114091_bib77","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-025-59278-0","article-title":"Injectable extracellular vesicle hydrogels with tunable viscoelasticity for depot vaccine","volume":"16","author":"Bhatta","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114091_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41541-023-00686-y","article-title":"Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles","volume":"8","author":"Manfredi","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib79","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"W\u00fcthrich","year":"2003","journal-title":"The Journal of experimental medicine"},{"key":"10.1016\/j.isci.2025.114091_bib80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/EC.00279-10","article-title":"Candida albicans Als3, a multifunctional adhesin and invasin","volume":"10","author":"Liu","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.isci.2025.114091_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925821","article-title":"Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib82","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/173.3.684","article-title":"Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics","volume":"173","author":"Angiolella","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib83","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1080\/22221751.2020.1840927","article-title":"Preventing Candida albicans from subverting host plasminogen for invasive infection treatment","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.isci.2025.114091_bib84","article-title":"Baicalein Acts against Candida albicans by Targeting Eno1 and Inhibiting Glycolysis","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.114091_bib85","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.vaccine.2019.03.061","article-title":"Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis","volume":"37","author":"Xin","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib86","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/s41423-020-00576-6","article-title":"Priming with FLO8-deficient Candida albicans induces Th1-biased protective immunity against lethal polymicrobial sepsis","volume":"18","author":"Lv","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib87","doi-asserted-by":"crossref","first-page":"e0039323","DOI":"10.1128\/spectrum.00393-23","article-title":"Erg6 acts as a downstream effector of the transcription factor Flo8 to regulate biofilm formation in Candida albicans","volume":"11","author":"Jin","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.114091_bib88","doi-asserted-by":"crossref","first-page":"e01828-17","DOI":"10.1128\/mBio.01828-17","article-title":"The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Cryptococcus neoformans","volume":"9","author":"Masso-Silva","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000953","article-title":"Transcription factors Mat2 and Znf2 operate cellular circuits orchestrating opposite-and same-sex mating in Cryptococcus neoformans","volume":"6","author":"Lin","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2025.114091_bib90","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/EC.05138-11","article-title":"Cell wall chitosan is necessary for virulence in the opportunistic pathogen Cryptococcus neoformans","volume":"10","author":"Baker","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.isci.2025.114091_bib91","doi-asserted-by":"crossref","first-page":"e01872-17","DOI":"10.1128\/mBio.01872-17","article-title":"Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and cryptococcal species","volume":"8","author":"Specht","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.114091_bib92","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/02770903.2024.2419452","article-title":"In silico B-cell epitope prediction and molecular docking of Aspergillus allergens targeting improved ABPA diagnosis","volume":"62","author":"Agrawal","year":"2025","journal-title":"J. Asthma"},{"key":"10.1016\/j.isci.2025.114091_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659752","article-title":"CcpA-and Shm2-Pulsed myeloid dendritic cells induce T-Cell activation and enhance the neutrophilic oxidative burst response to Aspergillus Fumigatus","volume":"12","author":"Page","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib94","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.vaccine.2018.04.026","article-title":"Viable spores of Coccidioides posadasii \u0394cps1 are required for vaccination and provide long lasting immunity","volume":"36","author":"Shubitz","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","article-title":"Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group","volume":"148","author":"Pappagianis","year":"2012","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib96","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tim.2024.11.006","article-title":"Funding and collaboration inequalities in infectious disease research\u2013why does it matter?","volume":"33","author":"Malavige","year":"2025","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41541-023-00795-8","article-title":"Development and use of machine learning algorithms in vaccine target selection","volume":"9","author":"Bravi","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib98","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41564-022-01287-6","article-title":"Prediction of effector protein structures from fungal phytopathogens enables evolutionary analyses","volume":"8","author":"Seong","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/jof10010043","article-title":"Design of a multi-epitope vaccine against Histoplasma capsulatum through immunoinformatics approaches","volume":"10","author":"Marques","year":"2024","journal-title":"J. Fungi"},{"key":"10.1016\/j.isci.2025.114091_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114091_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76891-z","article-title":"AI based predictive acceptability model for effective vaccine delivery in healthcare systems","volume":"14","author":"Qureshi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114091_bib102","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41598-020-57906-x","article-title":"In silico Design of a Multivalent Vaccine Against Candida albicans","volume":"10","author":"Tarang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114091_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.863234","article-title":"Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi","volume":"13","author":"Araf","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib104","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/vaccines11020364","article-title":"Secreted Aspartyl Proteinases Targeted Multi-Epitope Vaccine Design for Candida dubliniensis Using Immunoinformatics","volume":"11","author":"Akhtar","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.isci.2025.114091_bib105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s43141-022-00415-3","article-title":"Design of a multi-epitope vaccine against the pathogenic fungi Candida tropicalis using an in silico approach","volume":"20","author":"Akhtar","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.isci.2025.114091_bib106","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41564-024-01662-5","article-title":"A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens","volume":"9","author":"Zhou","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104728","article-title":"Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome","volume":"150","author":"Krishnan G","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.isci.2025.114091_bib108","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12668-025-01840-7","article-title":"Nano-Enhanced Antifungal Therapy in Diabetic Patients with Candidiasis","volume":"15","author":"Adwani","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.isci.2025.114091_bib109","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","article-title":"Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines","volume":"18","author":"Han","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.isci.2025.114091_bib110","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","article-title":"Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate","volume":"15","author":"Fu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114091_bib111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.114091_bib112","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.114091_bib113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","article-title":"Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action","volume":"5","author":"Pifferi","year":"2021","journal-title":"Nat. Rev. Chem"},{"key":"10.1016\/j.isci.2025.114091_bib114","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41467-024-45158-6","article-title":"Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114091_bib115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.114091_bib116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.molmed.2024.02.013","article-title":"mRNA vaccine platforms to prevent bacterial infections","volume":"30","author":"Bergstrom","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.isci.2025.114091_bib117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41541-024-00837-9","article-title":"Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax","volume":"9","author":"Kunkeaw","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2025.114091_bib118","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41590-023-01562-6","article-title":"mRNA vaccine against malaria tailored for liver-resident memory T cells","volume":"24","author":"Ganley","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib119","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/pharmaceutics16080983","article-title":"Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum","volume":"16","author":"Elalouf","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2025.114091_bib120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s43141-023-00560-3","article-title":"Immunoinformatic-guided designing and evaluating protein and mRNA-based vaccines against Cryptococcus neoformans for immunocompromised patients","volume":"21","author":"Elalouf","year":"2023","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.isci.2025.114091_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/ffunb.2022.940884","article-title":"Systemic Candidiasis in Mice: New Insights From an Old Model","volume":"3","author":"Jungnickel","year":"2022","journal-title":"Front. Fungal Biol."},{"key":"10.1016\/j.isci.2025.114091_bib122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-1-4939-7104-6_23","article-title":"Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis","volume":"1625","author":"Segal","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.114091_bib123","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/13693780701644140","article-title":"Animal models: an important tool in mycology","volume":"45","author":"Capilla","year":"2007","journal-title":"Med. Mycol."},{"key":"10.1016\/j.isci.2025.114091_bib124","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12281-012-0126-6","article-title":"Animal models in mycology: what have we learned over the past 30 years","volume":"7","author":"Kirkpatrick","year":"2013","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.isci.2025.114091_bib125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fmicb.2012.00291","article-title":"Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models","volume":"3","author":"Hole","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib126","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-022-01087-8","article-title":"Animal models for COVID-19: advances, gaps and perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.114091_bib127","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1128\/IAI.00359-15","article-title":"Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae","volume":"83","author":"Urb","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114091_bib128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1099\/jmm.0.000590","article-title":"Innate and adaptive immune response to chronic pulmonary infection of hyphae of Aspergillus fumigatus in a new murine model","volume":"66","author":"Wang","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib129","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1182\/bloodadvances.2022007474","article-title":"Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma","volume":"6","author":"Little","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2025.114091_bib130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib131","unstructured":"Pappagianis, D., and Group, V.F.V.S. (2012). Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am. Rev. Respir. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib132","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00002512-200522060-00004","article-title":"Influenza vaccination in the elderly: impact on hospitalisation and mortality","volume":"22","author":"Nichol","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.isci.2025.114091_bib133","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archinte.163.9.1089","article-title":"Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity","volume":"163","author":"Voordouw","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.isci.2025.114091_bib134","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jmv.23630","article-title":"Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine","volume":"85","author":"Song","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2025.114091_bib135","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2026713","article-title":"Advances in the progress of monoclonal antibodies for rabies","volume":"18","author":"Fan","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.isci.2025.114091_bib136","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/403121","article-title":"Human monoclonal antibody-based therapy in the treatment of invasive candidiasis","volume":"2013","author":"Bugli","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.isci.2025.114091_bib137","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/jof6040247","article-title":"A One Health Approach to Combatting Sporothrix brasiliensis: Narrative Review of an Emerging Zoonotic Fungal Pathogen in South America","volume":"6","author":"Rossow","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.isci.2025.114091_bib138","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s40588-022-00181-3","article-title":"Emerging Fungal Infections: from the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem","volume":"9","author":"Langfeldt","year":"2022","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.isci.2025.114091_bib139","article-title":"A One Health approach to overcoming fungal disease and antifungal resistance","volume":"15","author":"Woods","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.isci.2025.114091_bib140","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0332","article-title":"Tackling emerging fungal threats to animal health, food security and ecosystem resilience","volume":"371","author":"Fisher","year":"2016","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.isci.2025.114091_bib141","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/encyclopedia3030064","article-title":"Fungi in a one health perspective","volume":"3","author":"Sim\u00f5es","year":"2023","journal-title":"Encyclopedia"},{"key":"10.1016\/j.isci.2025.114091_bib142","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrmicro1449","article-title":"Fungal quorum sensing: in vino veritas?","volume":"4","author":"Molloy","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114091_bib143","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s42003-020-01342-0","article-title":"Fungal-bacterial interaction selects for quorum sensing mutants with increased production of natural antifungal compounds","volume":"3","author":"Albarracin Orio","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2025.114091_bib144","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41467-018-04223-7","article-title":"Designer cells programming quorum-sensing interference with microbes","volume":"9","author":"Sedlmayer","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114091_bib145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13099-023-00559-8","article-title":"The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Pathog."},{"key":"10.1016\/j.isci.2025.114091_bib146","first-page":"291","volume":"22","author":"Calnan","year":"2020"},{"key":"10.1016\/j.isci.2025.114091_bib147","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing\u2013an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114091_bib148","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2021.7707","article-title":"When vaccine apathy, not hesitancy, drives vaccine disinterest","volume":"325","author":"Wood","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.114091_bib149","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11266-023-00630-7","article-title":"The Fight for Global Health Justice: The Advocacy of International Humanitarian and Development NGOs During the COVID-19 Pandemic","volume":"35","author":"Noh","year":"2024","journal-title":"Voluntas."},{"key":"10.1016\/j.isci.2025.114091_bib150","first-page":"152","article-title":"The role of non-governmental organizations in vaccine development and delivery","volume":"22","author":"Walton","year":"2017","journal-title":"Int. J. Health Gov."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:48:16Z","timestamp":1783475296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225023521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":150,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589004225023521"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114091","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in fungal vaccine development: Progress in the face of emerging challenges","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114091"}}